Herb Profile
Bacopa
Bacopa monnieri
Clinical data analysis found limited/modest evidence for memory/nootropic effects; no two healthy subject studies showed the same significant cognitive test changes, and more studies are needed.
Last reviewed: •6 sources citedReport a correctionProfile-wide ·A Strong
Use extra caution — May support memory/learning in some contexts; evidence is modest and slow onset/standardization dependent. Details
- Evidence
- Strong Evidence
- Typical onset
- Varies by prep
- Safety rating
- High caution
- Best for
- Antioxidant, Cognitive, Neuroprotective, Stress resilience
- Avoid / review if
- Sedatives, Thyroid Medications (Possible Interaction)
Verdict: BacopaMaybe
Bottom line
A genuine memory herb, but it rewards patience — the trials that work run for months. Useless as a same-day focus tool.
- Evidence confidence
- Moderate for memory — but only with patience
- Expected onset
- Weeks — meaningful effects around 8–12 weeks
- Give it
- 8–12 weeks
Safety: Can cause GI upset; take with food. May interact with thyroid and sedative medications.
On the evidence: Multiple trials show memory benefits over 12 weeks; short-term effects are negligible.
Best for
- Long-term memory and learning
- Consistent daily use over months
- Non-stimulant cognitive support
Not ideal for
- Same-day focus or alertness
- Anyone wanting fast results
- Sensitive stomachs (take with food)
How strong is the evidence?Moderate
Why not higher
- Benefits only appear after ~8–12 weeks of daily use
- Effect sizes are modest and mostly on memory/recall
- Extracts (e.g. standardized bacosides) differ between products
Why not lower
- Multiple randomized trials show real memory benefits over 12 weeks
- A plausible mechanism and long traditional use
Practical takeaway: Worth it only if you will commit to daily use for 2–3 months for memory and learning. Useless as a same-day focus tool, and take it with food.
Safety
Safety & Cautions
May support memory/learning in some contexts; evidence is modest and slow onset/standardization dependent. | Do not claim proven nootropic, ADHD treatment, Alzheimer’s treatment, or instant focus boost.
High caution
Caution level: High. Multiple caution categories apply, or the record uses avoid/contraindication language.
- Interaction-AwareMedication or interaction context is explicitly noted.
- Hormonal Activity ContextHormone-adjacent wording is present and should be interpreted carefully.
Detailed safety fields
Pregnancy, breastfeeding, and contraindications
- Sedatives
- Thyroid Medications (Possible Interaction)
Safety classifications
- Interaction-Aware: Medication or interaction context is explicitly noted.
- Hormonal Activity Context: Hormone-adjacent wording is present and should be interpreted carefully.
Full safety note
- May support memory/learning in some contexts; evidence is modest and slow onset/standardization dependent. | Do not claim proven nootropic, ADHD treatment, Alzheimer’s treatment, or instant focus boost. | Position as a cautious Focus pillar page with “evidence is slower and memory oriented” framing.
Safety labels
- Interaction-Aware
- Hormonal Activity Context
Evidence-based safety
Caution when combined
Severity and certainty are shown separately. A high-priority caution can still be theoretical: these pairings are screened from shared contraindication mechanisms and are not automatically documented clinical interactions. Provenance identifies the source fields that produced each flag; it does not upgrade the certainty of the pairwise claim.
Moderate Caution
68 flagged pairingsSedation / CNS depression
Moderate Caution
68 flagged pairingsSedation / CNS depression
Representative pairings are shown below. Large mechanism groups are intentionally summarized to keep profiles focused and crawl-efficient.
Sedation / CNS depressionCertainty: Theoretical
Data provenance recorded for 68 of 68 pairings in this mechanism group.
- American Yellow Lotus — Theoretical interaction certainty
- Artemisia Absinthium — Theoretical interaction certainty
- Ashwagandha (Withania somnifera) — Theoretical interaction certainty
- Black Seed — Theoretical interaction certainty
- Black Tea — Theoretical interaction certainty
- Blue Lotus — Theoretical interaction certainty
- Calamus — Theoretical interaction certainty
- Catuba — Theoretical interaction certainty
- Celastrus Paniculatus — Theoretical interaction certainty
- Chamomile — Theoretical interaction certainty
- Chinese Skullcap — Theoretical interaction certainty
- Coriandrum Sativum — Theoretical interaction certainty
+56 more pairings share this mechanism. Use the Safety Checker to review a specific combination.
Evidence
Evidence Summary
Evidence lens
Most useful for practical interpretation when safety context also fits.
StrongStrong Evidence
Human clinical evidence: Present in source signals
Mechanistic / preclinical: Mechanism mapped — Oxidative Stress Modulation · Neurotransmitter Modulation · Neuroprotective Activity
Research maturity: Established research — Long Term Human Evidence May Be Limited.
Safety boundary: Safety note available — May support memory/learning in some contexts; evidence is modest and slow onset/standardization dependent.
This profile cites 6 human studies.
Study design details
Evidence Grade
Grade A: Strong Evidence
Evaluation of methodological rigor, population reach, and evidence alignment.
- Design Match
- Meta-analysis
- Risk of Bias
- Low
- Consistency
- Consistent
Strongest recorded design is a meta-analysis, drawn from 12 recorded studies, 10 in people. No disagreement is recorded across them.
How evidence grades work
Each grade reflects the strength and consistency of published human evidence — not marketing claims. Grades are based on study count, design quality, effect size, consistency, and recency.
- Strong
- Multiple RCTs, consistent direction, adequate effect size
- Moderate
- Some RCTs or consistent observational data in humans
- Preliminary / Mixed
- Animal or in-vitro only, or conflicting human data
- Traditional / Theoretical
- Traditional use only; no controlled human trials
Clinical Study Summaries (11)8 human evidence sources · 5 human trials · Participant totals not consistently reported · Consistency not yet classifiable
Filter by study class
Showing 11 of 11 studies.
What the evidence actually shows
This table contains 11 structured sources, including 8 human evidence sources; 5 are human trials.
| Study | Design | N | Dose | Duration | Population | Outcome | Result & magnitude | Source |
|---|---|---|---|---|---|---|---|---|
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | Network estimates favored higher-dose Bacopa (≥600 mg/day) for working and short-term memory in selected comparisons. | High-dose Bacopa (≥600 mg/day) ranked highest for working memory and significantly outperformed lower-dose Bacopa, high/low-dose Ginkgo, and placebo; benefits were also reported for short-term memory. | PubMed → |
Background | Meta-analysis Statistically combines results from multiple eligible studies; confidence still depends on the quality, consistency, and directness of those studies. | — | — | — | — | — | Randomized-trial synthesis supports possible memory-domain effects after chronic Bacopa monnieri exposure, but standardized-extract identity and treatment duration are central to interpretation. The evidence does not establish an immediate or universal nootropic effect. | PubMed → |
Plant-derived nootropics and human cognition: A systematic review Lorca C et al. · Crit Rev Food Sci Nutr · 2023 Background | Systematic review Uses a predefined method to find and evaluate relevant studies, but may or may not pool their results statistically. | — | — | — | — | — | — | PubMed → |
PubMed · J Altern Complement Med · 2008 Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | — | — | — | — | — | — | PubMed → |
Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | — | — | — | — | — | Adds randomized evidence for cognition, stress, and fatigue outcomes in healthy adults. | Secondary outcomes showed greater reductions in self-reported stress reactivity and in fatigue/stress after a cognitively demanding task. | PubMed → |
Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | — | — | — | — | — | Some attention/verbal-fluency or end-point cognitive signals were reported, but overall cognition was not consistently significant and sleep quality did not clearly improve. | PubMed → |
Show 5 more studies
Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | — | — | — | — | — | Within-group analyses showed significant memory/IQ improvements in both Bacopa and Centella groups; mean total memory score increased 9.28% with Bacopa and 13.45% with Centella. | PubMed → |
Background | Randomized controlled trial Randomly assigns participants to interventions or controls, reducing many sources of bias when the trial is conducted well. | — | — | — | — | — | Preliminary post-intervention findings suggested Brahmi Ghrita partially reversed increases in tCho, tCr, and myo-inositol and improved auditory verbal learning and digit-span-forward performance. | PubMed → |
Pharmacological attributes of Bacopa monnieri extract: Current updates and clinical manifestation Fatima U et al. · Front Nutr · 2022 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
Nootropic Herbs, Shrubs, and Trees as Potential Cognitive Enhancers Malík M et al. · Plants (Basel) · 2023 Background | Narrative review Summarizes selected literature without the full prespecified search and selection methods of a systematic review. | — | — | — | — | — | — | PubMed → |
J. Brimson; S. Brimson; M. Prasanth; Premrutai Thitilertdecha; D. Malar; T. Tencomnao · Scientific Reports · 2021 Background | Other / unclear The study design is not yet classified clearly enough to infer its place in the evidence hierarchy. | — | — | — | — | — | — | Source → |
Dosing & Timing
- No standardized dose
- Dose varies by standardized extract and bacoside content. | Bacopa monnieri extracts/standardized bacoside products; combinations should not be credited solely to bacopa.
How Bacopa works
Simplified mechanism pathway based on preclinical and pharmacological evidence. Does not confirm clinical efficacy.
Mechanism Pathway — How Bacopa Works
CompoundTarget / ReceptorMechanismEffect / Outcome
Mechanisms & biological pathways (preclinical)
- Oxidative Stress Modulation
- Neurotransmitter Modulation
- Neuroprotective Activity
Active Compounds
Key constituents studied in Bacopa, with full pharmacology and safety profiles.
Compare related active botanicals
Explore botanicals with similar chemistry, effects, or safety considerations in the Botanical Activity Atlas.
Compare & Sourcing
Compare side-by-side tradeoffs or verify active marker guidelines.
Sourcing options
Bacopa product picks
Recommendation status
Product recommendations are not shown for this profile because the current site safety and monetization policy does not permit them.
Product form & quality guidelines
When sourcing Bacopa, verify the label for:
- Standardized extract: Confirm active content percentages on the supplement facts panel (e.g. standardized to specific marker compounds) rather than simple raw herb weights.
- Third-party testing: Look for independent purity labels (USP, NSF, ConsumerLab, or Eurofins) to ensure the product is free from heavy metals, solvents, and contaminants.
- Form bioavailability: Ensure the form matches evidence-supported configurations (e.g. standardized active extracts like bacosides, withanolides, or curcuminoids) for optimal onset and digestion tolerance.
Safety first · Harm reduction
This information is educational and not medical advice. Start low, avoid risky combinations, and consult a licensed clinician before making health decisions—especially if you use medications, have diagnosed conditions, or are pregnant/breastfeeding.
Learn how we evaluate confidence, safety, and intensity on the methodology page.
Founder & Head Researcher · Oak Ridge, TN · Last reviewed August 2026
Editorial Review
Checked against primary sources, cited evidence, and contraindication language before publication. Evidence claims, safety language, and affiliate modules are reviewed independently. Not personal medical advice.
Help improve this profile
Was this useful for your research?
These controls record only the page and the structured choice you make when analytics consent is enabled. Please don’t include personal medical information in research requests.
Was this evidence summary clear?
Did you find what you were researching?
Free safety checklist
Get the Bacopa research notes
Evidence summaries, dosing context, and safety updates for this herb — straight to your inbox.
We use your email to send the checklist and occasional evidence-first supplement updates. Unsubscribe anytime. Privacy policy.